No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy
No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy have?
No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy has 113 citations in the OpenAlex counts ScholarIQ stores.
When was No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy published?
No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy has 2008 year in the ScholarIQ index.
What is the open-access status of No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy?
No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy has closed oa status in the ScholarIQ index.
What is the DOI of No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy?
The DOI for No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy is on the source record.
What is the PMID of No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy?
The PMID for No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy is on the source record.
What is the OpenAlex record for No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy?
The OpenAlex for No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy is on the source record.